HKD 0.21
(0.48%)
Breakdown | 2022 | 2021 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -42.16 Million | -64.47 Million | -9.74 Million | 55.81 Million | -90.33 Million | -75.37 Million |
Net Income | -62.22 Million | -91.05 Million | -145.68 Million | -149.24 Million | -134.72 Million | -92.86 Million |
Depreciation & Amortization | 46.6 Million | 55.5 Million | 80.99 Million | 95.57 Million | 5.13 Million | 7.74 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -8.02 Million | 12.15 Million | 38.31 Million | 95.29 Million | 38.49 Million | 19.32 Million |
Other non-cash items | -18.52 Million | -41.08 Million | 16.62 Million | 14.19 Million | 760 Thousand | -9.57 Million |
Investing Cash Flow | 44.05 Million | 1.95 Million | 15.28 Million | -42 Million | -9.32 Million | 38.44 Million |
Investments in PPE | -1.43 Million | -97.2 Thousand | -30 Thousand | -1.56 Million | -6.41 Million | -1.54 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 45.49 Million | 2.05 Million | 15.31 Million | -40.44 Million | -2.91 Million | 39.99 Million |
Financing Cash Flow | 42.21 Million | 21.89 Million | 68.64 Million | -32.36 Million | 95.9 Million | 42.03 Million |
Debt repayment | -376.17 Million | - | -200.81 Million | -485.22 Million | -442.42 Million | -474.99 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | 102.71 Million | 102.71 Million | 102.71 Million | 93.03 Million |
Other Financing Activities | 418.38 Million | 21.89 Million | 166.74 Million | 350.13 Million | 435.61 Million | 423.99 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | 7.28 Million | 12.15 Million | 22.25 Million | 1.15 Million | 11.77 Million | 13.27 Million |
Other working capital | -15.31 Million | - | 16.05 Million | 94.14 Million | 26.72 Million | 6.04 Million |
Cash at beginning of period | 54.09 Million | 13.76 Million | 13.76 Million | 32.31 Million | 36.07 Million | 30.96 Million |
Cash at end of period | 98.18 Million | 87.94 Million | 87.94 Million | 13.76 Million | 32.31 Million | 36.07 Million |
Capital Expenditure | -1.43 Million | -97.2 Thousand | -30 Thousand | -1.56 Million | -6.41 Million | -1.54 Million |
Effect of forex changes on cash | - | 114.81 Million | - | - | - | - |
Net cash flow / Change in cash | 44.09 Million | 74.18 Million | 74.18 Million | -18.55 Million | -3.76 Million | 5.11 Million |
Free Cash Flow | -43.6 Million | -64.57 Million | -9.77 Million | 54.25 Million | -96.74 Million | -76.91 Million |
Breakdown | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 | 2022 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -8.74 Million | -8.74 Million | -10.47 Million | -62.22 Million | -10.47 Million | -19.04 Million |
Depreciation & Amortization | 8.73 Million | 8.73 Million | 9.16 Million | 46.6 Million | 9.16 Million | 14.13 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | 3.64 Million | -8.02 Million | 3.64 Million | - |
Other non-cash items | -3.27 Million | -3.27 Million | -8.63 Million | -18.52 Million | -8.63 Million | -9.86 Million |
Investing Cash Flow | 30.58 Million | 30.58 Million | 18.41 Million | 44.05 Million | 18.41 Million | 3.61 Million |
Investments in PPE | -384 Thousand | -384 Thousand | -56 Thousand | -1.43 Million | -56 Thousand | -663 Thousand |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 30.96 Million | 30.96 Million | 18.47 Million | 45.49 Million | 18.47 Million | 4.27 Million |
Financing Cash Flow | -64.22 Million | -64.22 Million | -16.33 Million | 42.21 Million | -16.33 Million | 37.42 Million |
Debt repayment | - | - | - | -376.17 Million | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -64.22 Million | -64.22 Million | -16.33 Million | 418.38 Million | -16.33 Million | 37.42 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | 3.64 Million | 7.28 Million | 3.64 Million | - |
Other working capital | - | - | - | -15.31 Million | - | - |
Cash at beginning of period | - | - | - | 54.09 Million | 106.63 Million | - |
Cash at end of period | -36.94 Million | -36.94 Million | -4.22 Million | 98.18 Million | - | 106.63 Million |
Capital Expenditure | -384 Thousand | -384 Thousand | -56 Thousand | -1.43 Million | -56 Thousand | -663 Thousand |
Effect of forex changes on cash | - | - | - | - | -102.41 Million | 80.36 Million |
Net cash flow / Change in cash | -36.94 Million | -36.94 Million | -4.22 Million | 44.09 Million | -106.63 Million | 106.63 Million |
Free Cash Flow | -3.67 Million | -3.67 Million | -6.35 Million | -43.6 Million | -6.35 Million | -15.43 Million |
ICI
MAHMF
SKE
4406
MEDXF
MKC-V